Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7891)
All Articles published online
|
Publishing Process of This Article
|
Mar 14, 2015 (publication date) through Apr 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Qi XS, Bao YX, Bai M, Xu WD, Dai JN, Guo XZ. Nonselective beta-blockers in cirrhotic patients with no or small varices: A meta-analysis. World J Gastroenterol 2015; 21(10): 3100-3108 [PMID: 25780311 DOI: 10.3748/wjg.v21.i10.3100] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i10/3100.htm |
| Number | Citing Articles |
| 1 |
David Vidal González, Karla Paola Pérez López, Saúl André Vera Nungaray, Luis Guillermo Moreno Madrigal. Treatment of refractory ascites: Current strategies and new landscape of non-selective beta-blockers. Gastroenterología y Hepatología 2022; 45(9): 715 doi: 10.1016/j.gastrohep.2022.02.004
|
| 2 |
|
| 3 |
Susana G. Rodrigues, Yuly P. Mendoza, Jaime Bosch. Beta-blockers in cirrhosis: Evidence-based indications and limitations. JHEP Reports 2020; 2(1): 100063 doi: 10.1016/j.jhepr.2019.12.001
|
| 4 |
Davide Roccarina, Lawrence MJ Best, Suzanne C Freeman, Danielle Roberts, Nicola J Cooper, Alex J Sutton, Amine Benmassaoud, Maria Corina Plaz Torres, Laura Iogna Prat, Mario Csenar, Sivapatham Arunan, Tanjia Begum, Elisabeth Jane Milne, Maxine Tapp, Chavdar S Pavlov, Brian R Davidson, Emmanuel Tsochatzis, Norman R Williams, Kurinchi Selvan Gurusamy. Primary prevention of variceal bleeding in people with oesophageal varices due to liver cirrhosis: a network meta-analysis. Cochrane Database of Systematic Reviews 2021; 2021(4) doi: 10.1002/14651858.CD013121.pub2
|
| 5 |
Irakoze Laurent, Siying Tang, Manirakiza Astère, Kan Ran Wang, Shuhua Deng, Ling Xiao, Qi Fu Li. Liquid L-thyroxine versus tablet L-thyroxine in patients on L- thyroxine replacement or suppressive therapy: a meta-analysis. Endocrine 2018; 61(1): 28 doi: 10.1007/s12020-018-1574-8
|
| 6 |
Curt J. Daniels, Elisa A. Bradley, Mike J. Landzberg, Jamil Aboulhosn, Robert H. Beekman, Wendy Book, Michelle Gurvitz, Anitha John, Binu John, Ariane Marelli, Bradley S. Marino, L. LuAnn Minich, John J. Poterucha, Elizabeth B. Rand, Gruschen R. Veldtman. Fontan-Associated Liver Disease. Journal of the American College of Cardiology 2017; 70(25): 3173 doi: 10.1016/j.jacc.2017.10.045
|
| 7 |
Mathias Jachs, Thomas Reiberger. Pharmacotherapy for Liver Cirrhosis and Its Complications. 2022; : 127 doi: 10.1007/978-981-19-2615-0_8
|
| 8 |
Dimitrios S. Karagiannakis, Nikolaos D. Karakousis, Theodoros Androutsakos. B-Blockers in Liver Cirrhosis: A Wonder Drug for Every Stage of Portal Hypertension? A Narrative Review. Biomedicines 2023; 12(1): 57 doi: 10.3390/biomedicines12010057
|
| 9 |
Xiangbo Xu, Xiaozhong Guo, Frank Tacke, Xiaodong Shao, Xingshun Qi. Use of nonselective β blockers after variceal eradication in cirrhotic patients undergoing secondary prophylaxis of esophageal variceal bleeding: a critical review of current evidence. Therapeutic Advances in Chronic Disease 2019; 10: 204062231986269 doi: 10.1177/2040622319862693
|
| 10 |
KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications. Clinical and Molecular Hepatology 2020; 26(2): 83 doi: 10.3350/cmh.2019.0010n
|
| 11 |
Barbara J. Deal, Marc Gewillig, Constantine Mavroudis. Diagnosis and Management of Adult Congenital Heart Disease. 2018; : 163 doi: 10.1016/B978-0-7020-6929-1.00012-5
|
| 12 |
Cosmas Rinaldi Adithya Lesmana, Monica Raharjo, Rino A. Gani. Managing liver cirrhotic complications: Overview of esophageal and gastric varices. Clinical and Molecular Hepatology 2020; 26(4): 444 doi: 10.3350/cmh.2020.0022
|
| 13 |
Maria Corina Plaz Torres, Lawrence MJ Best, Suzanne C Freeman, Danielle Roberts, Nicola J Cooper, Alex J Sutton, Davide Roccarina, Amine Benmassaoud, Laura Iogna Prat, Norman R Williams, Mario Csenar, Dominic Fritche, Tanjia Begum, Sivapatham Arunan, Maxine Tapp, Elisabeth Jane Milne, Chavdar S Pavlov, Brian R Davidson, Emmanuel Tsochatzis, Kurinchi Selvan Gurusamy. Secondary prevention of variceal bleeding in adults with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: a network meta-analysis. Cochrane Database of Systematic Reviews 2021; 2022(9) doi: 10.1002/14651858.CD013122.pub2
|
| 14 |
Umesha Boregowda, Chandraprakash Umapathy, Nasir Halim, Madhav Desai, Arpitha Nanjappa, Subramanyeswara Arekapudi, Thimmaiah Theethira, Helen Wong, Marina Roytman, Shreyas Saligram. Update on the management of gastrointestinal varices. World Journal of Gastrointestinal Pharmacology and Therapeutics 2019; 10(1): 1-21 doi: 10.4292/wjgpt.v10.i1.1
|
| 15 |
Xingshun Qi, Xiaozhong Guo, Hongyu Li, Xu Liu, Han Deng. Knowledge about non-invasive diagnostic tests for varices in liver cirrhosis: A questionnaire survey to the Gastroenterology Branch of the Liaoning Medical Association, China. Gastroenterology Report 2016; 4(2): 141 doi: 10.1093/gastro/gov031
|
| 16 |
Kurinchi Selvan Gurusamy, Emmanuel Tsochatzis. Primary prevention of bleeding in people with oesophageal varices due to liver cirrhosis: a network meta-analysis. Cochrane Database of Systematic Reviews 2018; doi: 10.1002/14651858.CD013121
|
| 17 |
Eun Sun Jang. Brief Review of the Revised Korean Association for the Study of the Liver Clinical Practice Guidelines for Liver Cirrhosis: Varices, Hepatic Encephalopathy and Related Complications. The Korean Journal of Gastroenterology 2019; 74(5): 274 doi: 10.4166/kjg.2019.74.5.274
|
| 18 |
Danielle Roberts, Emmanuel Tsochatzis, Kurinchi Selvan Gurusamy. Treatment for bleeding oesophageal varices in people with decompensated liver cirrhosis: a network meta-analysis. Cochrane Database of Systematic Reviews 2018; doi: 10.1002/14651858.CD013155
|
| 19 |
Sara Blasco-Algora, José Masegosa-Ataz, Sonia Alonso, Maria-Luisa Gutiérrez, Conrado Fernández-Rodriguez. Non-selective β-blockers in advanced cirrhosis: a critical review of the effects on overall survival and renal function. BMJ Open Gastroenterology 2016; 3(1): e000104 doi: 10.1136/bmjgast-2016-000104
|
| 20 |
Irakoze Laurent, Manirakiza Astère, Kan Ran Wang, Qing-feng Cheng, Qi Fu Li. Efficacy and Time Sensitivity of Amniotic Membrane treatment in Patients with Diabetic Foot Ulcers: A Systematic Review and Meta-analysis. Diabetes Therapy 2017; 8(5): 967 doi: 10.1007/s13300-017-0298-8
|
| 21 |
Alexander Dechêne. Critical Care for Potential Liver Transplant Candidates. 2019; : 163 doi: 10.1007/978-3-319-92934-7_10
|
| 22 |
Daoming Zhang, Junjian Deng, Xufeng Guo, Yongfa Zheng, Ximing Xu. Nomogram model for predicting esophsagogastric varices in hepatocellular carcinoma with cirrhosis. European Journal of Gastroenterology & Hepatology 2023; 35(3): 342 doi: 10.1097/MEG.0000000000002496
|
| 23 |
Danielle Roberts, Lawrence MJ Best, Suzanne C Freeman, Alex J Sutton, Nicola J Cooper, Sivapatham Arunan, Tanjia Begum, Norman R Williams, Dana Walshaw, Elisabeth Jane Milne, Maxine Tapp, Mario Csenar, Chavdar S Pavlov, Brian R Davidson, Emmanuel Tsochatzis, Kurinchi Selvan Gurusamy. Treatment for bleeding oesophageal varices in people with decompensated liver cirrhosis: a network meta-analysis. Cochrane Database of Systematic Reviews 2021; 2021(4) doi: 10.1002/14651858.CD013155.pub2
|
| 24 |
Kurinchi Selvan Gurusamy, Emmanuel Tsochatzis. Secondary prevention of bleeding in people with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: a network meta-analysis. Cochrane Database of Systematic Reviews 2018; doi: 10.1002/14651858.CD013122
|
| 25 |
Shi-Hao Xu, Fang Wu, Le-Hang Guo, Wei-Bing Zhang, Hui-Xiong Xu. Liver fibrosis index-based nomograms for identifying esophageal varices in patients with chronic hepatitis B related cirrhosis. World Journal of Gastroenterology 2020; 26(45): 7204-7221 doi: 10.3748/wjg.v26.i45.7204
|
| 26 |
Maria Antonella Burza, Hanns-Ulrich Marschall, Laura Napoleone, Antonio Molinaro. The 35-year odyssey of beta blockers in cirrhosis: any gender difference in sight?. Pharmacological Research 2017; 119: 20 doi: 10.1016/j.phrs.2017.01.015
|
| 27 |
K Shibata, K Yokoyama, R Yamauchi, K Matsumoto, S Himeno, T Nagata, T Higashi, T Kitaguchi, H Fukuda, N Tsuchiya, A Fukunaga, K Takata, T Tanaka, Y Takeyama, S Shakado, S Sakisaka, F Hirai|. Long-term outcomes of hemostatic therapy for variceal bleeding and the challenge pending in the post-direct-acting antivirals era. Acta Gastro Enterologica Belgica 2022; 85(1): 7 doi: 10.51821/85.1.9276
|
| 28 |
Bingqiong Wang, Jialing Zhou, Xiaoning Wu, Yameng Sun, Lei Li, Ping Li, Minghui Li, Wei Jiang, Mingyi Xu, Bo Feng, Xiaoyuan Xu, Jilin Cheng, Wen Xie, Tao Han, Xiaozhong Wang, Hai Li, Hongxin Piao, Xinyu Zhao, Shuyan Chen, Tongtong Meng, Qiushuang Guan, Fandong Meng, Yuanyuan Kong, Xiaojuan Ou, Jidong Jia, Hong You. Carvedilol Plus NUC for Patients With HBV-Compensated Cirrhosis Under Virological Suppression: A Randomized Open-Label Trial. American Journal of Gastroenterology 2024; 119(4): 700 doi: 10.14309/ajg.0000000000002569
|
| 29 |
Mathias Jachs, Thomas Reiberger. Prevention of Variceal Bleeding and Rebleeding by Nonselective Beta-Blockers. Clinics in Liver Disease 2021; 25(2): 311 doi: 10.1016/j.cld.2021.01.004
|
| 30 |
Yung-Yu Hsieh, Wei-Ming Chen, Kao-Chi Chang, Te-Sheng Chang, Chao-Hung Hung, Yao-Hsu Yang, Shui-Yi Tung, Kuo-Liang Wei, Chen-Heng Shen, Cheng-Shyong Wu, Yuan-Jie Ding, Jing-Hong Hu, Yu-Ting Huang, Meng-Hung Lin, Chung-Kuang Lu, Yi-Hsiung Lin, Ming-Shyan Lin. Direct-Acting Antivirals Reduce the De Novo Development of Esophageal Varices in Patients with Hepatitis C Virus Related Liver Cirrhosis. Viruses 2023; 15(1): 252 doi: 10.3390/v15010252
|
| 31 |
Mattias Mandorfer, Thomas Reiberger. Beta blockers and cirrhosis, 2016. Digestive and Liver Disease 2017; 49(1): 3 doi: 10.1016/j.dld.2016.09.013
|
| 32 |
Mattias Mandorfer, Markus Peck-Radosavljevic, Thomas Reiberger. Prevention of progression from small to large varices: are we there yet? An updated meta-analysis. Gut 2017; 66(7): 1347 doi: 10.1136/gutjnl-2016-312814
|
| 33 |
Yeon Seok Seo. Prevention and management of gastroesophageal varices. Clinical and Molecular Hepatology 2018; 24(1): 20 doi: 10.3350/cmh.2017.0064
|
| 34 |
N. N. Smagina. Primary prevention of bleeding esophageal varices in patients with liver cirrhosis. Health and Ecology Issues 2020; (3): 56 doi: 10.51523/2708-6011.2020-17-3-8
|
| 35 |
V. L. Korobka, V. D. Pasetchnikov, R. V. Korobka, E. S. Pak, A. M. Shapovalov. Use of endoscopic band ligation alone and in combination with nonselective beta blockers for prevention of variceal bleeding in ascites patients on the liver transplant waiting list. Russian Journal of Transplantology and Artificial Organs 2022; 24(3): 42 doi: 10.15825/1995-1191-2022-3-42-50
|
| 36 |
Kareem Abu-Elmagd, Basem Soliman, Ajai Khanna, Masato Fujiki, Bijan Eghtesad, Guilherme Costa. Surgical Procedures on the Cirrhotic Patient. 2017; : 89 doi: 10.1007/978-3-319-52396-5_7
|
| 37 |
Dmitry Victorovich Garbuzenko, Nikolay Olegovich Arefyev. Primary prevention of bleeding from esophageal varices in patients with liver cirrhosis: An update and review of the literature. Journal of Evidence-Based Medicine 2020; 13(4): 313 doi: 10.1111/jebm.12407
|
| 38 |
Thomas Reiberger, Mattias Mandorfer. Beta adrenergic blockade and decompensated cirrhosis. Journal of Hepatology 2017; 66(4): 849 doi: 10.1016/j.jhep.2016.11.001
|
| 39 |
David Vidal González, Karla Paola Pérez López, Saúl André Vera Nungaray, Luis Guillermo Moreno Madrigal. Treatment of refractory ascites: Current strategies and new landscape of non-selective beta-blockers. Gastroenterología y Hepatología (English Edition) 2022; 45(9): 715 doi: 10.1016/j.gastre.2022.02.003
|
| 40 |
Sarah‐Louise Gillespie, Timothy P. Hanrahan, Don C. Rockey, Avik Majumdar, Peter C. Hayes. Review article: controversies surrounding the use of carvedilol and other beta blockers in the management of portal hypertension and cirrhosis. Alimentary Pharmacology & Therapeutics 2023; 57(5): 454 doi: 10.1111/apt.17380
|
| 41 |
Ashish Kumar, Praveen Sharma, Shrihari A. Anikhindi, Ritesh Prajapati, Rachit Agarwal, Bhupendra Sharma, Naresh Bansal, Vikas Singla, Anil Arora. Can Non-Selective Beta-Blockers (NSBBs) Prevent Enlargement of Small Esophageal Varices in Patients with Cirrhosis? A Meta-analysis. Journal of Clinical and Experimental Hepatology 2017; 7(4): 275 doi: 10.1016/j.jceh.2017.09.003
|
| 42 |
Xingshun Qi, Hongyu Li, Xu Liu, Hui Yao, Guohong Han, Fengrong Hu, Lichun Shao, Xiaozhong Guo. Novel insights into the development of portal vein thrombosis in cirrhosis patients. Expert Review of Gastroenterology & Hepatology 2015; 9(11): 1421 doi: 10.1586/17474124.2015.1083856
|
| 43 |
Ankit Bhardwaj, Chandan Kumar Kedarisetty, Chitranshu Vashishtha, Ajeet Singh Bhadoria, Ankur Jindal, Guresh Kumar, Ashok Choudhary, S M Shasthry, Rakhi Maiwall, Manoj Kumar, Vikram Bhatia, Shiv Kumar Sarin. Carvedilol delays the progression of small oesophageal varices in patients with cirrhosis: a randomised placebo-controlled trial. Gut 2017; 66(10): 1838 doi: 10.1136/gutjnl-2016-311735
|
| 44 |
|